Cargando…
Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells
BACKGROUND: The limitation of current biomarker of early stage ovarian cancer and the anatomical location of ovarian (depths of the pelvic) make ovarian cancer difficult to be detected in early stage. Growing evidence shows exosomes as key information transmitters, it carried molecules, such as miRN...
Autores principales: | Cheng, Lin, Zhang, Kun, Qing, Yunan, Li, Dong, Cui, Manhua, Jin, Peng, Xu, Tianmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977352/ https://www.ncbi.nlm.nih.gov/pubmed/31969186 http://dx.doi.org/10.1186/s13048-020-0609-y |
Ejemplares similares
-
A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies
por: Cheng, Lin, et al.
Publicado: (2017) -
Focus on Mesenchymal Stem Cell-Derived Exosomes: Opportunities and Challenges in Cell-Free Therapy
por: Cheng, Lin, et al.
Publicado: (2017) -
Are ovarian cancer stem cells the target for innovative immunotherapy?
por: Wang, Liang, et al.
Publicado: (2018) -
MicroRNA-363 inhibits ovarian cancer progression by inhibiting NOB1
por: Lin, Yang, et al.
Publicado: (2017) -
Retraction: MicroRNA-363 inhibits ovarian cancer progression by inhibiting NOB1
por: Lin, Yang, et al.
Publicado: (2023)